These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37012548)

  • 1. Incremental value of radiomics-based heterogeneity to the existing risk criteria in predicting recurrence of hepatocellular carcinoma after liver transplantation.
    Nie P; Zhang J; Miao W; Duan S; Wang T; Zhang J; Gu J; Wang N; Zhang R; Wang X; Yang G; Rao W; Wang Z
    Eur Radiol; 2023 Sep; 33(9):6608-6618. PubMed ID: 37012548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study.
    Yang G; Nie P; Yan L; Zhang M; Wang Y; Zhao L; Li M; Xie F; Xie H; Li X; Xiang F; Wang N; Cheng N; Zhao X; Wang N; Wang Y; Chen C; Yun C; Cui J; Duan S; Zhang R; Hao D; Wang X; Wang Z; Niu H
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2949-2959. PubMed ID: 35344062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
    Cha DI; Kang TW; Jeong WK; Kim JM; Choi GS; Joh JW; Yi NJ; Ahn SH
    Eur Radiol; 2024 Jan; 34(1):498-508. PubMed ID: 37505248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio.
    Xia W; Ke Q; Guo H; Wang W; Zhang M; Shen Y; Wu J; Xu X; Yan S; Yu J; Zhang M; Zheng S
    BMC Cancer; 2017 Jan; 17(1):14. PubMed ID: 28056901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study.
    Al-Ameri AAM; Wei X; Liu P; Lin L; Shao Z; Xie H; Zhou L; Zheng S; Xu X
    Ann Transplant; 2019 Aug; 24():489-498. PubMed ID: 31427563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram.
    Zhao JW; Shu X; Chen XX; Liu JX; Liu MQ; Ye J; Jiang HJ; Wang GS
    Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):543-550. PubMed ID: 35705443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation.
    Wang MX; Chen D; Zhao YY; Yang B; Jiang JP; Zeng FJ; Wei L; Chen ZS
    Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):378-383. PubMed ID: 32622825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of survival and tumor recurrence rates in patients undergoing liver transplantation for hepatitis B-related hepatocellular carcinoma using Milan, Shanghai Fudan and Hangzhou criteria.
    Gao T; Xia Q; Qiu DK; Feng YY; Chi JC; Wang SY; Xi ZF; Zhang JJ; Xu N; Chen SY; Qiu YL; Shen LW; Zhou TT; Dong XJ; Li QG; Li H
    J Dig Dis; 2013 Oct; 14(10):552-8. PubMed ID: 23782458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation.
    Guo D; Gu D; Wang H; Wei J; Wang Z; Hao X; Ji Q; Cao S; Song Z; Jiang J; Shen Z; Tian J; Zheng H
    Eur J Radiol; 2019 Aug; 117():33-40. PubMed ID: 31307650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a nomogram for predicting liver transplantation prognosis in hepatocellular carcinoma.
    He L; Ji WS; Jin HL; Lu WJ; Zhang YY; Wang HG; Liu YY; Qiu S; Xu M; Lei ZP; Zheng Q; Yang XL; Zhang Q
    World J Gastroenterol; 2024 Jun; 30(21):2763-2776. PubMed ID: 38899335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of Milan, University of California San Francisco, and Up-To-7 Criteria in Predicting Tumor Recurrence Following Deceased-Donor Liver Transplant in Patients With Hepatocellular Carcinoma.
    Saberi B; Garonzik-Wang J; Ma M; Ajayi T; Kim A; Luu H; Jakhete N; Pustavoitau A; Anders RA; Georgiades C; Kamel I; Ottmann S; Philosophe B; Cameron AM; Gurakar A
    Exp Clin Transplant; 2020 Aug; 18(4):463-469. PubMed ID: 30084757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence After Liver Transplantation: The Recurrent Hepatocellular Carcinoma-Initial, Maximum, Last Classification.
    Vutien P; Dodge J; Bambha KM; Nordstrom EM; Gralla J; Campbell K; Levek C; Nydam T; Fix O; Ioannou G; Biggins SW
    Liver Transpl; 2019 Apr; 25(4):559-570. PubMed ID: 30706653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study.
    Piñero F; Costa P; Boteon YL; Duque SH; Marciano S; Anders M; Varón A; Zerega A; Poniachik J; Soza A; Machaca MP; Menéndez J; Zapata R; Vilatoba M; Muñoz L; Maraschio M; Fauda M; McCormack L; Gadano A; Boin IS; García JHP; Silva M
    Ann Hepatol; 2018 Mar; 17(2):256-267. PubMed ID: 29469048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation.
    Teng F; Wang GH; Tao YF; Guo WY; Wang ZX; Ding GS; Shi XM; Fu ZR
    World J Gastroenterol; 2014 Aug; 20(31):10900-7. PubMed ID: 25152592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma.
    Li JH; Chen T; Xing H; Li RD; Shen CH; Zhang QB; Tao YF; Wang ZX
    Hepatobiliary Pancreat Dis Int; 2023 Jun; 22(3):245-252. PubMed ID: 35534342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
    Hsu CC; Chen CL; Wang CC; Lin CC; Yong CC; Wang SH; Liu YW; Lin TL; Lee WF; Lin YH; Chan YC; Wu YJ; Eng HL; Cheng YF
    Transplantation; 2016 Sep; 100(9):1925-32. PubMed ID: 27306534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.